miR-665 is significantly upregulated in breast cancer tissues and promotes cancer cell proliferation, invasion, and metastasis by inhibiting NR4A3 to activate the MEK signaling pathway, thereby functioning as an oncomiR in breast cancer progression (Zhao et al., 2019). Here, NR4A3 is linked to breast cancer.